Aiomics

Aiomics

Private
BerlinHealthcare & Life Scienceshttps://aiomics.io

Last Round

Pre Seed

Sep 4, 2025

Est. Valuation

$11.65M

Total Funding Raised

$2.33M

Momentum Score

75 /100

Company Overview

Aiomics is a healthcare technology company that provides an AI-driven co-pilot platform designed to capture, structure, and validate clinical documentation for healthcare providers in Europe.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Vertical SaaS, EHR & EMR, NLP & Conversational AI, Compliance

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

AI medical scribeAI medical copilotclinical documentationpatient intake automationhealthcare data platformrevenue cycle managementAI documentation platformmedical knowledge graphunstructured data capturehuman-in-the-loophealthcare NLPEHR integrationHIS integrationHL7 FHIRmedical AIopenEHR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aiomics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Aiomics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Pre SeedSep 4, 2025

Key People

Founding team and executive leadership

Nikita Tarasov

Co-Founder CTO

Founding Team

Sven Jungmann

Founder CEO

Founding Team

Aiomics Investors

Notable investors and investment history

InvestorRounds
Rule30Pre Seed
Calm/Storm VenturesPre Seed
Vorwerk VenturesPre Seed
Norrsken EvolvePre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 27, 2026

    Grew 50% QoQ, from 6 to 9 employees.

  • Apr 15, 2026

    Monthly visitors increased 104% MoM.

Aiomics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aiomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aiomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerlin
Employee Range9
Year Founded2025
Last FundingSep 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.